Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chandra Bhagat Pharma markets and distributes a wide range of generic medicines, antibiotics, antivirals, anti-cancer drugs, and biosimilars—several of which (such as biosimilar filgrastim, urokinase, L-asparaginase, and streptokinase) have obtained Indian regulatory approval and are commercialized in India and certain international markets[8][1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chandra Bhagat Pharma.